Read the latest reports on Western Europe, with local insight, sp...
Read the latest reports on Western Europe, with local insight, specialist knowledge and a comprehensive breakdown of key market data. Our research identifies key strategic themes relevant across the region, while also providing a more granular unders...
Cough, cold and allergy (hay fever) sales are expected to be slightly down in 2023. This is partly a result of the very strong performance seen in the previous year, as the lifting of COVID-19 related restrictions led to greater social contact and…
Cough remedies and decongestants, which had seen strong growth during the pandemic period, saw more moderate growth in 2022 and 2023 as the contagion receded and public concern waned. Current value sales growth partly reflects inflationary pressures,…
Sales of cough, cold and allergy (hay fever) remedies are seeing strong growth in current value terms in 2023. This is partly due to inflation-driven price increases (also the consequence of supply shortages in some cases) and an increase in cough,…
Cough, cold and allergy (hay fever) remedies received a strong sales boost in 2022 due to consumers returning to working in the office more frequently again and kids returning to in-school classes. This led to consumers spending more time among other…
In the upcoming years, consumers and businesses face an array of challenges, with income inequality, mass migration and rising uncertainty about another crisis being among the major ones. Nevertheless, within this lie untapped opportunities. This…